REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. (2015)

First Author: King A

Attributed to: MRC Centre for Regenerative Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2015-007700

PubMed Identifier: 25795699

Publication URI: http://europepmc.org/abstract/MED/25795699

Type: Journal Article/Review

Volume: 5

Parent Publication: BMJ open

Issue: 3

ISSN: 2044-6055